Non-invasive diagnostic test realizes the potential of circulating DNA for detection of multiple diseases
The novel technology was developed by Yinon Ben-Neriah, MD, PhD, Blumenthal Professor of Cancer Research, Lautenberg Center for Immunology, Hebrew University-Hadassah Medical School, with generous support by AMRF (The Dr. Miriam...
Conference focusing on innovations in nanotechnology, sensors, coating materials, electronic and 3D printing, to take place on March 29 at Hebrew University Edmond J. Safra campus.
During 2015, Yissum founded a record number of eight companies...
Neteera Technologies Raises 2 Million US Dollars.
Novel technology, based on electromagnetic properties of human sweat ducts, enables biometric identification along with monitoring of stress, fatigue, pain, alcohol influence, drug abuse...
Melodea develops environmentally-friendly, nano-crystalline cellulose based products from side streams of the paper industry
Capital to be used for completion of on-going Phase 2b study of ladostigil, for treatment of mild cognitive impairment, and preparations for pivotal Phase 3 trial
The first projects to be funded by Agrinnovation include protective coating for extension of shelf-life of fruits and vegetables, controlled release of drugs for farm animals, and invention for protection of plants via electronic means.
Results show positive trends in primary end point of delaying or preventing onset of Alzheimer’s diseaseFinal results expected in Q3 2016, following 3 years of treatment
The novel technology by Prof. Nissim Benvenisty utilizes stem cells as models for genetic disorders and enables large scale screening of small molecule drugs
Qlight Nanotech’s staff will remain at the Company’s site at the Hebrew University of Jerusalem, and will function as the research base for Merck for quantum-materials for the display and lighting industry
Yissum Research Development Company Ltd., the Technology Transfer Company of the Hebrew University of Jerusalem, announced today that it had signed multiple research and licensing agreements in the area of advanced materials with ICL (NYSE and...
Santen Pharmaceutical Co., Ltd. today announced it received approval of the Marketing Authorization Application (MAA) for Ikervis from the European Commission. Ikervis is approved for treatment of severe keratitis in adult patients with dry eye...